06/02/2026
Read about Dr. Andy Russo and his postdoc Dr. Adriana Della Pietra’s latest work exploring progress over the past five years in targeting CGRP pathways—an area that has reshaped how we understand and treat migraine, and where the science is headed next to improve patient outcomes.
The past 5 years of success with calcitonin gene-related peptide (CGRP) based drugs has transformed migraine into a relatively treatable neurological disorder. There are now eight monoclonal antibo...